What is the typical time course and symptoms of Lyme disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lyme Disease: Typical Time Course and Symptoms

Lyme disease progresses through three distinct stages with an incubation period of typically 7-14 days (range 3-30 days) after a tick bite, beginning with erythema migrans and potentially advancing to disseminated neurologic, cardiac, and arthritic manifestations if untreated. 1

Incubation Period

The time from tick bite to symptom onset is typically 7-14 days, though it can be as short as 3 days or as long as 30 days 1, 2. Some patients remain asymptomatic despite serologic evidence of infection 1.

Stage 1: Early Localized Disease (Days to Weeks)

Primary manifestation:

  • Erythema migrans (EM) - the pathognomonic rash occurring in 50-80% of patients 1, 3, 4
  • Appears at the tick bite site as a gradually expanding erythematous lesion
  • Can be homogeneously red or have central clearing (target-like appearance) 5
  • May have vesicles or pustules at the center in ~5% of cases 5
  • Not typically scaly or pruritic 5

Accompanying nonspecific symptoms:

  • Fever, malaise, fatigue
  • Headache
  • Myalgia and arthralgia
  • Generalized lymphadenopathy 1, 6

Important caveat: In a large minority (38.4%) of patients, viral-like symptoms may appear before the rash is noticed, potentially delaying diagnosis 7.

Stage 2: Early Disseminated Disease (Days to Weeks After EM)

Spirochetes disseminate via cutaneous, lymphatic, and bloodborne routes 1. This stage occurs days to weeks after the initial EM lesion appears.

Dermatologic:

  • Multiple secondary erythema migrans lesions
  • Borrelia lymphocytoma (rare, bluish-red skin infiltrate, often at ear lobe or nipples) 3

Neurologic (15% of untreated patients):

  • Lymphocytic meningitis
  • Cranial neuropathy, especially facial nerve palsy (Bell's palsy) - can be bilateral
  • Radiculoneuritis
  • Meningoradiculitis 1, 3, 8

Cardiac (5-8% of patients, rare):

  • Myocarditis
  • Transient atrioventricular block of varying degree
  • Cardiomegaly 1, 8

Musculoskeletal:

  • Migratory joint and muscle pains
  • May occur with or without objective joint swelling 1

Stage 3: Late Disseminated Disease (Weeks to Months After Infection)

Occurs weeks to months after initial infection in untreated or inadequately treated patients 1.

Arthritic (60% of untreated patients):

  • Intermittent swelling and pain of large, weight-bearing joints (especially the knee)
  • Most common objective manifestation of late disease
  • May be intermittent or chronic 1, 8

Neurologic:

  • Chronic axonal polyneuropathy
  • Encephalopathy with cognitive disorders, sleep disturbance, fatigue, personality changes 1

Dermatologic:

  • Acrodermatitis chronica atrophicans (ACA) - associated with B. afzelii
  • Begins with bluish-red discoloration and doughy infiltration
  • Progresses to skin atrophy, sometimes with sclerodermic changes
  • Typically appears several years after EM 3

Critical Clinical Pearls

Geographic variation: European presentations differ from U.S. cases due to different Borrelia species. B. garinii (Europe) causes more neurologic disease, B. afzelii causes ACA, while B. burgdorferi sensu stricto (U.S.) may cause more arthritis 3, 4.

Mortality: Lyme disease is rarely, if ever, fatal 1.

Post-treatment syndrome: An ill-defined post-Lyme disease syndrome with persistent symptoms can occur after treatment 1.

Diagnosis timing: Early diagnosis and treatment are crucial - erythema migrans is sufficiently distinctive to allow clinical diagnosis without laboratory confirmation 1, 2, 5. Serologic testing is too insensitive in the first 2 weeks to be diagnostically helpful 5.

Related Questions

What are the characteristic appearances of an early Lyme disease rash and the recommended treatment regimen?
What is the recommended treatment for a patient with suspected Lyme disease who was bitten by a tick in an endemic area and presents with erythema migrans or compatible systemic symptoms?
In a 40-year-old man with a 20‑cm erythema migrans rash on his back, fatigue, headache, and mild chills after recent hiking, and no fever or joint pain, what is the most appropriate next step in management?
Can active Lyme disease worsen eczema symptoms?
How should joint pain after a tick bite be evaluated and managed, including appropriate antibiotic therapy, Lyme serology testing, and symptomatic pain control?
How should a 76-year-old patient with prior neck surgery who is taking gabapentin and tizanidine be managed after presenting with syncope and hypotension?
In an elderly male taking apalutamide (Nubeqa) and relugolix (Orgovyx), could his irritability be a side effect of the combined androgen deprivation therapy, and how should it be evaluated and managed?
How should I monitor and adjust levothyroxine therapy in a patient on thyroid hormone replacement, including considerations for iron deficiency?
How effective is doxycycline for early Lyme disease in adults, and what is the recommended dose and duration?
What is the recommended treatment for non‑germinal center (ABC) diffuse large B‑cell lymphoma?
What is the appropriate titration schedule to increase memantine (Namenda) to 20 mg daily and concurrently taper risperidone in a patient with dementia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.